A hapten is a small molecule or otherwise weak immunogen that is too small on its own to present a recognizable epitope. Immunizing with the compound directly rarely triggers a useful response, because the immune system needs a larger structure to engage. The work of a hapten antibody project is therefore to attach the hapten to a carrier so the immune system can see it, while keeping intact the very part of the molecule that defines specificity — otherwise the antibody raised will recognize the carrier, not the compound of interest.
We prepare anti-hapten antibodies by combining chemistry, biology, and materials expertise to modify the small molecule without destroying its characteristic structure, then coupling it to a carrier chosen for the target. The aim is an immunogen that provokes a response directed at the hapten itself, so the antibody produced reports the compound rather than the scaffold it rides on.
The Carrier Problem
| Issue | Effect on the project | How we address it |
| Hapten too small to be seen | No response, or response to carrier only | Attach to a carrier protein |
| Specific structure lost in modification | Antibody misses the target compound | Preserve the characteristic epitope during coupling |
| One carrier insufficient | Weak or narrow response | Combine carriers and adapt their design |
| Cross-reactivity with scaffold | False signal in the assay | Screen against the free hapten, not the conjugate |
Raising an antibody against a small molecule is a chemistry problem as much as an immunology one. We treat the modification and the carrier choice as central to the project, not as a routine coupling step, and we screen candidates against the free hapten so the reagent you receive recognizes the compound you care about rather than the protein it was attached to.